Literature DB >> 12034701

Bilateral uveitis after intravesical BCG immunotherapy for bladder carcinoma.

M Wertheim, N Astbury.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12034701      PMCID： PMC1771147          DOI： 10.1136/bjo.86.6.706

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  9 in total

1.  Severe uveitis followed by reactive arthritis after bacillus Calmette-Guérin therapy.

Authors:  G Chevrel; C Zech; P Miossec
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

2.  Arthritis after bacillus Calmette-Guerin therapy.

Authors:  D W Puett; H A Fuchs
Journal:  Ann Intern Med       Date:  1992-09-15       Impact factor: 25.391

3.  Arthritis and iritis after bacillus Calmette-Guérin therapy.

Authors:  D Missioux; J Hermabessiere; B Sauvezie
Journal:  J Rheumatol       Date:  1995-10       Impact factor: 4.666

4.  Effect of BCG on delayed hypersensitivity responses of patients with neoplastic disease.

Authors:  J E Sokal; C W Aungst; T Han
Journal:  Int J Cancer       Date:  1973-07-15       Impact factor: 7.396

5.  Endophthalmitis from Mycobacterium bovis-bacille Calmette-Guérin after intravesicular bacille Calmette-Guérin injections for bladder carcinoma.

Authors:  D P Han; K B Simons; C N Tarkanian; S T Moretti
Journal:  Am J Ophthalmol       Date:  1999-11       Impact factor: 5.258

6.  Arthritis and iritis after BCG therapy for bladder cancer.

Authors:  G E Price
Journal:  J Rheumatol       Date:  1994-03       Impact factor: 4.666

Review 7.  Polyarthritis following intravesical BCG immunotherapy. Report of a case and review of 26 cases in the literature.

Authors:  G Clavel; F Grados; G Cayrolle; R Bellony; I Leduc; B Lafont; J P Ducroix; P Fardellone
Journal:  Rev Rhum Engl Ed       Date:  1999-02

8.  Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancer.

Authors:  D L Lamm; V D Stogdill; B J Stogdill; R G Crispen
Journal:  J Urol       Date:  1986-02       Impact factor: 7.450

Review 9.  Bacillus Calmette-Guérin immunotherapy for superficial bladder cancer. New prospects for an old warhorse.

Authors:  M A O'Donnell; W C DeWolf
Journal:  Surg Oncol Clin N Am       Date:  1995-04       Impact factor: 3.495
  9 in total
  6 in total

1.  Bilateral orbital inflammation following intravesical bacille Calmette-Guérin immunotherapy for bladder cancer.

Authors:  Atsuya Takeuchi; Manzo Taguchi; Yasushi Satoh; Masahiro Ishida; Masaru Takeuchi
Journal:  Jpn J Ophthalmol       Date:  2012-02-18       Impact factor: 2.447

2.  Bilateral symmetrical corneal melting following intravesical Bacille Calmette-Guerin therapy for bladder carcinoma.

Authors:  Chandana Chakraborty; Kumaresh C Sarkar; Swati Majumdar; Krittika P Chaudhury
Journal:  Oman J Ophthalmol       Date:  2012-05

3.  Uveitis Following Treatment of Verruca Vulgaris with Intralesional Candida Antigen.

Authors:  Nicholas J Crowley; John C Hagan; Jonathan A Dyer; Tyler F Brundige
Journal:  Mo Med       Date:  2017 Sep-Oct

4.  The Association between QuantiFERON-TB Gold Test and Clinical Manifestations of Uveitis in the United States.

Authors:  Mehmet Yakin; Natasha Kesav; Shuk Kei Cheng; Sonny Caplash; Sapna Gangaputra; H Nida Sen
Journal:  Am J Ophthalmol       Date:  2021-05-02       Impact factor: 5.488

Review 5.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

6.  Drug-induced uveitis.

Authors:  Nikolas Js London; Sunir J Garg; Ramana S Moorthy; Emmett T Cunningham
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-03-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.